Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Homologous and heterologous boosting with third-dose BNT162b2 and CoronaVac: a randomized trial (Cobovax study) Proceeding/Conference:Options for the Control of Influenza XI | 2022 | ||
Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine Journal:Clinical Infectious Diseases | 2022 | ||
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine Journal:The Journal of Infectious Diseases | 2023 | ||
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated Vaccine Journal:The Journal of Infectious Diseases | 2022 |